Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet Extension in Primary Hyperparathyroidism
NCT00936988Phase 2Completed
- Sponsor
- Amgen
- Start
- Nov 2000
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cinacalcet in primary hyperparathyroidism (PHPT), sponsored by Amgen. Started Nov 2000; status: completed.
02
Drugs
cinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT00936988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936988.